MPZL3 and glioblastoma: The results demonstrated that MPZL3 expression positively correlated with the ImmuneScore in DLBC, GBM, KIRC, etc., but negatively correlated with the ImmuneScore in BLCA, CESC, COAD, etc. (Figure S7).